Immunotherapy with rituximab/interleukin 2 (IL-2) following autologous peripheral blood stem cell transplant (ASCT) as treatment for CD20 positive non-hodgkin’s lymphoma

✍ Scribed by L.A. Holmberg; D. Maloney; T. Gooley; W.I. Bensinger

• Book ID: 116278790
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 58 KB
• Volume: 12
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2005.11.356